Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Wagner, A D

Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jan 2007 - 82-87 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0923-7534

10.1093/annonc/mdl340 doi


Adenocarcinoma--drug therapy
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Deoxycytidine--administration & dosage
Disease Progression
Disease-Free Survival
Female
Fluorouracil--administration & dosage
Humans
Infusions, Intravenous
Male
Middle Aged
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Pancreatic Neoplasms--drug therapy
Quality of Life
Survival Rate
Time Factors
Treatment Outcome
Gemcitabine